ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 45.88%
This Quarter Est. Return
1 Year Est. Return
+45.88%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$166M
AUM Growth
+$20.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
45
New
Increased
Reduced
Closed

Top Buys

1
+$10.5M
2
+$10.2M
3
+$9.01M
4
CYTK icon
Cytokinetics
CYTK
+$8.8M
5
QTRX icon
Quanterix
QTRX
+$8.06M

Top Sells

1
+$12M
2
+$10.2M
3
+$9.36M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$6.87M
5
EPIX
ESSA Pharma
EPIX
+$6.07M

Sector Composition

1 Healthcare 99.56%
2 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IRON icon
26
Disc Medicine
IRON
$3.14B
$1.15M 0.69%
+9,469
RGLS
27
DELISTED
Regulus Therapeutics
RGLS
$968K 0.58%
140,149
-4,929
BLSA
28
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$730K 0.44%
73,306
-9,971
LRMR icon
29
Larimar Therapeutics
LRMR
$283M
$403K 0.24%
+34,943
MCRB icon
30
Seres Therapeutics
MCRB
$124M
– –
-3,163
ADPT icon
31
Adaptive Biotechnologies
ADPT
$2.25B
– –
-168,172
ARGX icon
32
argenx
ARGX
$51.7B
– –
-8,104
BDSX icon
33
Biodesix
BDSX
$57.8M
– –
-381,378
BIO icon
34
Bio-Rad Laboratories Class A
BIO
$8.19B
– –
-2,979
CNC icon
35
Centene
CNC
$18.2B
– –
-164,489
EPIX
36
DELISTED
ESSA Pharma
EPIX
– –
-212,525
FBRX icon
37
Forte Biosciences
FBRX
$145M
– –
-2,656
GH icon
38
Guardant Health
GH
$11.9B
– –
-24,443
GLTO icon
39
Galecto
GLTO
$6.78M
– –
-2,439
JAZZ icon
40
Jazz Pharmaceuticals
JAZZ
$7.92B
– –
-52,702
MREO
41
Mereo BioPharma
MREO
$269M
– –
-1,618,328
SHC icon
42
Sotera Health
SHC
$4.46B
– –
-421,341
VERV
43
DELISTED
Verve Therapeutics
VERV
– –
-24,790
LENZ
44
LENZ Therapeutics
LENZ
$710M
– –
-7,291
ASLN
45
DELISTED
ASLAN Pharmaceuticals Limited American Depositary Shares
ASLN
– –
-29,852
1
2